Between Dec 19, 2024 and Jan 2, 2025, datasets can be submitted to DRUM but will not be processed until after the break. Staff will not be available to answer email during this period, and will not be able to provide DOIs until after Jan 2. If you are in need of a DOI during this period, consider Dryad or OpenICPSR. Submission responses to the UDC may also be delayed during this time.

Browsing by Subject "immunotolerization"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    The role of bone marrow-derived progenitor cells in pancreatic cancer
    (2021-12) Edwards, Rachel
    Pancreatic ductal adenocarcinoma (PDA) is the most common type of pancreatic cancer, and it has an extremely poor prognosis for patients. PDA is distinct from many other cancer types in that it has a robust desmoplastic reaction deposited by the large number of pancreatic stellate cells (PSC) present within the tumor microenvironment (TME). In the human disease, the number of PSC can be so high that the number of quiescent, resident PSC present in the normal pancreas could not undergo enough rounds of proliferation without becoming a transformed cell type to result in the number of activated PSC observed in the tumor. Review articles have posited that mesenchymal stem cells (MSC) are one source of these cells for nearly a decade even though, to our knowledge, no one has conclusively shown this to be true. In this work, we set out to show this to be true, but our findings largely contradicted this hypothesis. We attempted to show that MSC home to PDA through multiple different methods, which are described in the following chapters. A bone marrow transplantation (BMT) method was employed to transplant two distinctly labelled stem cell populations in our GEMM of pancreatic cancer with Kras, p53, and Cre mutations (KPC). The results were inconclusive for our hypothesis because we found that MSC could not be transplanted into and reconstitute the mesenchymal niche in the bone marrow in the same manner as hematopoietic stem cells (HSC). A parabiosis surgical model was used to connect the circulation between a genetically engineered mouse model (GEMM) with fluorescently labelled MSC in the bone marrow and our KPC model. This was done to observe homing from resident, labelled MSC to overcome the limitations of transplanting MSC. We were unable to observe any signs of fluorescent MSC in the pancreas of diseased mice. Other subcutaneous (SQ) and injection models were used to compare our models and results with previous literature to gain a better understanding of the limitations of each system. We found that artifacts of less physiologically relevant models of disease may have contributed to the misunderstanding of pancreas cancer biology for over a decade.